• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

作者信息

Haque T, Crawford D H

机构信息

Department of Medical Microbiology, University of Edinburgh Medical School, UK.

出版信息

Springer Semin Immunopathol. 1998;20(3-4):375-87. doi: 10.1007/BF00838050.

DOI:10.1007/BF00838050
PMID:9870252
Abstract
摘要

相似文献

1
Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.供体与受体类型的爱泼斯坦-巴尔病毒在移植后淋巴细胞增生性疾病中的作用。
Springer Semin Immunopathol. 1998;20(3-4):375-87. doi: 10.1007/BF00838050.
2
The antiviral prophylaxis of post-transplant lymphoproliferative disorder.移植后淋巴增生性疾病的抗病毒预防
Springer Semin Immunopathol. 1998;20(3-4):437-53. doi: 10.1007/BF00838054.
3
Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.针对异基因骨髓移植后并发的爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的过继性免疫治疗。
Springer Semin Immunopathol. 1998;20(3-4):455-91. doi: 10.1007/BF00838055.
4
Immunotherapy for Epstein-Barr virus-associated malignancies.针对爱泼斯坦-巴尔病毒相关恶性肿瘤的免疫疗法。
Drug News Perspect. 2010 May;23(4):221-8. doi: 10.1358/dnp.2010.23.4.1439500.
5
Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.移植后淋巴增殖性疾病中的爱泼斯坦-巴尔病毒基因表达
Springer Semin Immunopathol. 1998;20(3-4):389-403. doi: 10.1007/BF00838051.
6
Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation.预防骨髓移植后爱泼斯坦-巴尔病毒淋巴增殖性疾病。
J Immunother. 2001 Jul-Aug;24(4):283-4. doi: 10.1097/00002371-200107000-00002.
7
Epstein-Barr virus and posttransplant lymphoproliferative disease.爱泼斯坦-巴尔病毒与移植后淋巴细胞增生性疾病
J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):442-4. doi: 10.1097/00005176-200110000-00004.
8
B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.B淋巴细胞与爱泼斯坦-巴尔病毒：移植后淋巴细胞增生性疾病的教训
Autoimmun Rev. 2007 Dec;7(2):96-101. doi: 10.1016/j.autrev.2007.02.012. Epub 2007 Mar 26.
9
Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.爱泼斯坦-巴尔病毒相关淋巴增殖性疾病的免疫细胞治疗
Best Pract Res Clin Haematol. 2006;19(4):839-47. doi: 10.1016/j.beha.2006.06.003.
10
Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease.用于测量爱泼斯坦-巴尔病毒的半定量聚合酶链反应在有或无移植后淋巴细胞增生性疾病的小儿器官移植受者中测量病毒载量的效用。
Clin Infect Dis. 2001 Jul 15;33(2):145-50. doi: 10.1086/321806. Epub 2001 Jun 15.

引用本文的文献

1
Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.儿科肿瘤肾脏病学：传播信息的时刻-第二部分：儿童期恶性肿瘤幸存者和肾移植后恶性肿瘤的长期肾脏结局。
Pediatr Nephrol. 2022 Jun;37(6):1285-1300. doi: 10.1007/s00467-021-05172-y. Epub 2021 Sep 6.
2
Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.实体器官移植受者与干细胞移植受者循环中EBV DNA载量分布的差异及EBV mRNA表达模式的异质性。
Clin Dev Immunol. 2012;2012:543085. doi: 10.1155/2012/543085. Epub 2012 Dec 30.

本文引用的文献

1
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.
J Immunol. 1998 Jun 15;160(12):6204-9.
2
Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
J Pathol. 1998 Feb;184(2):177-84. doi: 10.1002/(SICI)1096-9896(199802)184:2<177::AID-PATH977>3.0.CO;2-C.
3
A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Transplantation. 1997 Oct 15;64(7):1028-34. doi: 10.1097/00007890-199710150-00015.
4
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
即刻早期和早期裂解周期蛋白是爱泼斯坦-巴尔病毒诱导的细胞毒性T细胞反应的常见靶点。
J Exp Med. 1997 May 5;185(9):1605-17. doi: 10.1084/jem.185.9.1605.
5
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.急性传染性单核细胞增多症中CD8 + T细胞的大量克隆性扩增。
Nat Med. 1996 Aug;2(8):906-11. doi: 10.1038/nm0896-906.
6
Growth of Epstein-Barr virus-associated B-lymphoproliferative disease tissue in a severe combined immunodeficient mouse.爱泼斯坦-巴尔病毒相关B淋巴细胞增殖性疾病组织在严重联合免疫缺陷小鼠体内的生长
Blood. 1996 Aug 1;88(3):1123-5.
7
Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients.供体爱泼斯坦-巴尔病毒（EBV）在移植器官中的传播会导致EBV血清阴性受者发生淋巴增殖性疾病。
J Gen Virol. 1996 Jun;77 ( Pt 6):1169-72. doi: 10.1099/0022-1317-77-6-1169.
8
Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.小儿移植患者外周血中感染爱泼斯坦-巴尔病毒的淋巴细胞负荷与淋巴增殖性疾病风险之间的直接相关性。
Blood. 1994 May 1;83(9):2715-22.
9
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.输注供体白细胞以治疗异基因骨髓移植后与爱泼斯坦-巴尔病毒相关的淋巴增殖性疾病。
N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703.
10
A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation.一名活体亲属肾供体作为移植后近乎致命的原发性爱泼斯坦-巴尔病毒感染的来源。
Transplantation. 1994 Oct 15;58(7):852-5.